Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01657162 · ClinicalTrials.gov registry record · Phase 3
Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis
A Phase 3 study, sponsored by Radius Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,139
- Enrollment target
NCT01657162 is a Phase 3 study that has completed, run by Radius Health. The registered enrollment target is 1,139 participants.
The verdict
NCT01657162, a Phase 3 study, has completed, sponsored by Radius Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,139 participants
- Enrollment target
Study Summary
The purpose of this study is to provide 24 months of standard of care data on participants previously enrolled in Study BA058-05-003 (NCT02653417).
Interventions
- DRUG Alendronate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,139 participants |
| Start Date | 2012-11-20 |
| Est. Completion | 2016-10-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01657162
The ClinicalTrials.gov registry entry for NCT01657162 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radius Health, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alendronate is the first listed.
NCT01657162 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01657162 about?
NCT01657162 is a clinical study titled "Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis". The purpose of this study is to provide 24 months of standard of care data on participants previously enrolled in Study BA058-05-003 (NCT02653417).
What is the current status of trial NCT01657162?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,139 participants. The study started on 2012-11-20. Estimated completion is 2016-10-03.
What interventions are being tested in trial NCT01657162?
The interventions under investigation include: Alendronate (DRUG).
Who is sponsoring clinical trial NCT01657162?
This trial is sponsored by Radius Health, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.